Product

Recombinant Human Plasma Gelsolin

Aliases

Recombinant human plasma gelsolin post-exposure, rhu-pGSN

1 clinical trial

1 indication

Indication

Decompression sickness

Clinical trial

Double-Blind, Placebo-Controlled Study Assessing the Efficacy and Safety/Tolerability of IV Rhu-pGSN as a Pre- or Post-Exposure Intervention to Mitigate Proinflammatory Responses to Decompression After High Pressure in a Hyperbaric Chamber

Status: Not yet recruiting, Estimated PCD: 2024-11-01